HRX Roundtable - Digital Health and AI Innovations in Pediatric & Adult Congenital Heart Disease Patients-Digital Health and AI Innovations in Pediatric & Adult Congenital Heart Disease Patients

Digital Health and AI Innovations in Pediatric & Adult Congenital Heart Disease Patients

Video Transcription

Video Summary

The session, moderated by the speaker, focused on the future of AI and machine learning in pediatrics and congenital heart disease. It featured experts including Charlie Brule, Artie Dallal, Kate Spivak, Nikon Bergen, Andy Blaufox, and Lisa Rowell. The discussion aimed to be open and interactive, touching on the significance of regulatory clearance for AI products in pediatrics. Experts noted the importance of having pediatric-specific algorithms and emphasized the need for accessible, affordable monitoring devices.<br /><br />Kate Spivak shared her experience with developing a product to sustain breastfeeding, highlighting the regulatory challenges faced. Nikon Bergen and others discussed the initial importance of indications for use in the development of new products, stressing financial viability as a key factor for innovation.<br /><br />Key issues raised included the need for child-friendly, interoperable devices that could easily integrate into electronic medical records, as well as the broader challenges of democratizing access to digital health tools for underserved populations. The group also discussed the potential of AI to aid in diagnostics and the importance of training algorithms to account for pediatric-specific nuances. The session concluded with calls for further collaboration to address these challenges and improve patient care in the pediatric and congenital heart disease space.

Keywords

AI in pediatrics

machine learning

congenital heart disease

regulatory clearance

pediatric-specific algorithms

affordable monitoring devices

digital health tools

interoperable devices

diagnostics